Xiangxue Pharmaceutical Co., Ltd. engages in the research and development, procurement, manufacture, delivery, and distribution of pharmaceutical products in China. It offers antivirotic oral liquids under the Xiangxue brand name; and healthcare supplements, as well as health solutions, such as food and beverage. Xiangxue Pharmaceutical Co., Ltd. has strategic partnership agreement with 111, Inc. to develop the Internet + Medicine model for China's traditional Chinese medicine industry. Xiangxue Pharmaceutical Co., Ltd. was founded in 1997 and is based in Guangzhou, China.
Metrics to compare | 300147 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300147PeersSector | |
---|---|---|---|---|
P/E Ratio | −5.6x | −11.2x | −0.5x | |
PEG Ratio | 0.04 | 0.00 | 0.00 | |
Price/Book | 5.2x | 2.9x | 2.6x | |
Price / LTM Sales | 3.0x | 3.9x | 3.3x | |
Upside (Analyst Target) | - | −16.5% | 40.3% | |
Fair Value Upside | Unlock | −8.9% | 5.1% | Unlock |